COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Rush University Medical Center

S. Jain

Management of AF patients with ACS

Lankenau

P. Kowey, D. Ice

Rhythm vs Rate: Has the Tide Changed Since the AFFIRM Trial?

The Texas Heart Institute

M. Razavi

"Pill in Pocket" Anticoagulation for Atrial Fibrillation: Fact, Fict…

Houston Methodist DeBakey Heart and Vascular Center

R. Passman

START: Stroke Prevention Through AFib Recognition and Treatment

The France Foundation

K. Newlin, L. Vanbrocklin

Five Things Every Internist Should Know About Anticoagulants

McMaster University Department of Medicine

S. Mithoowani

Management of Device Detected AF

Taya Glotzer

How Much Atrial Fibrillation Is Too Much: Contemporary and Future Ma…

Stanford Medicine

A. Perino

Acute DVT: When to and When Not to Intervene?

Venous Edge

S. Elias, C. Pena, C. Huff, R. Winokur, K. BROWN

Extended Anticoagulation for VTE

Jeffrey Weitz

Medical Management of DVT

NY Endovascular Summit

J. Goldfinger

"Pill-in-Pocket" - Anticoagulation for AF

Northwestern Medicine Cardiovascular Care

R. Passman

Atrial Fibrillation as the "Non-Ablationist" - A Continuum in Risk …

The American Society for Preventive Cardiology

L. Wang

AHA 2023 Insights: Apixaban for Stroke Prevention in Subclinical Atr…

AHA 2023 Insights

J. Healey

Duration of Anticoagulation: Provoked vs Unprovoked VTE

PERT Consortium 2022

G. Barnes

Therapy Post PCI: What Is the Rationale for DAPT and OAC? When to Us…

Complex Coronary Cases

U. Baber

Stroke Prevention in Atrial Fibrillation

Penn Medicine Heart and Vascular Center

D. Goldberg

ACC 2023: Can LAAC Be Considered a True Alternative to OAC?

ACC 2023 Conference Coverage

A. Natale

VTE Prevention in Medical Patients

PERT Consortium 2021

S. Schulman

Peri-Operative Management of Anticoagulation

Icahn School of Medicine at Mount Sinai

A. Dunn